Next Article in Journal
Electrochemical Characterization of Central Action Tricyclic Drugs by Voltammetric Techniques and Density Functional Theory Calculations
Next Article in Special Issue
Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability
Previous Article in Journal / Special Issue
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
 
 
Brief Report

Article Versions Notes

Pharmaceuticals 2019, 12(3), 115; https://doi.org/10.3390/ph12030115
Action Date Notes Link
article xml file uploaded 30 July 2019 11:06 CEST Original file -
article xml uploaded. 30 July 2019 11:06 CEST Update https://www.mdpi.com/1424-8247/12/3/115/xml
article pdf uploaded. 30 July 2019 11:06 CEST Version of Record https://www.mdpi.com/1424-8247/12/3/115/pdf
article html file updated 30 July 2019 11:08 CEST Original file -
article html file updated 26 September 2019 17:32 CEST Update -
article html file updated 13 February 2020 05:59 CET Update -
article html file updated 20 July 2022 06:08 CEST Update https://www.mdpi.com/1424-8247/12/3/115/html
Back to TopTop